According to Sage Therapeutics 's latest financial reports the company's current EPS (TTM) is -$9.92. In 2022 the company made an earnings per share (EPS) of -$8.98 a decrease over its 2021 EPS that were of -$7.80.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$9.92 | 10.47% |
2022 | -$8.98 | 15.13% |
2021 | -$7.80 | -167.18% |
2020 | $11.61 | -186.77% |
2019 | -$13.38 | 66.21% |
2018 | -$8.05 | 13.06% |
2017 | -$7.12 | 51.49% |
2016 | -$4.70 | 38.64% |
2015 | -$3.39 | 104.43% |
2014 | -$1.66 | 52.1% |
2013 | -$1.09 |